annual operating expenses:
$215.31M+$41.70M(+24.02%)Summary
- As of today (September 16, 2025), CYTK annual total operating expenses is $215.31 million, with the most recent change of +$41.70 million (+24.02%) on December 31, 2024.
- During the last 3 years, CYTK annual operating expenses has risen by +$118.51 million (+122.42%).
- CYTK annual operating expenses is now at all-time high.
Performance
CYTK Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$175.99M+$21.08M(+13.61%)Summary
- As of today (September 16, 2025), CYTK quarterly total operating expenses is $175.99 million, with the most recent change of +$21.08 million (+13.61%) on June 30, 2025.
- Over the past year, CYTK quarterly operating expenses has increased by +$47.98 million (+37.48%).
- CYTK quarterly operating expenses is now at all-time high.
Performance
CYTK quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CYTK Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.0% | +37.5% |
| 3 y3 years | +122.4% | +79.9% |
| 5 y5 years | +443.6% | +443.9% |
CYTK Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.4% | at high | +79.9% |
| 5 y | 5-year | at high | +443.6% | at high | +3494.9% |
| alltime | all time | at high | +1632.3% | at high | +405.5% |
CYTK Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $175.99M(+13.6%) |
| Mar 2025 | - | $154.91M(+0.9%) |
| Dec 2024 | $215.31M(+24.0%) | $153.58M(+10.6%) |
| Sep 2024 | - | $138.85M(+8.5%) |
| Jun 2024 | - | $128.01M(+2.6%) |
| Mar 2024 | - | $124.74M(+1.6%) |
| Dec 2023 | $173.61M(-2.5%) | $122.75M(+1.6%) |
| Sep 2023 | - | $120.79M(+0.6%) |
| Jun 2023 | - | $120.13M(-4.9%) |
| Mar 2023 | - | $126.30M(+0.0%) |
| Dec 2022 | $177.98M(+83.9%) | $126.25M(+16.0%) |
| Sep 2022 | - | $108.87M(+11.3%) |
| Jun 2022 | - | $97.84M(+26.3%) |
| Mar 2022 | - | $77.44M(+3.8%) |
| Dec 2021 | $96.80M(+83.3%) | $74.62M(+7.8%) |
| Sep 2021 | - | $69.20M(+26.3%) |
| Jun 2021 | - | $54.80M(+34.9%) |
| Mar 2021 | - | $40.61M(+11.5%) |
| Dec 2020 | $52.82M(+33.4%) | $36.41M(-802.3%) |
| Sep 2020 | - | -$5.18M(-116.0%) |
| Jun 2020 | - | $32.36M(+6.6%) |
| Mar 2020 | - | $30.36M(+28.1%) |
| Dec 2019 | $39.61M(+26.6%) | $23.71M(-0.9%) |
| Sep 2019 | - | $23.93M(-10.4%) |
| Jun 2019 | - | $26.72M(+9.0%) |
| Mar 2019 | - | $24.52M(+14.3%) |
| Dec 2018 | $31.28M(-14.2%) | $21.46M(+19.8%) |
| Sep 2018 | - | $17.91M(-23.5%) |
| Jun 2018 | - | $23.41M(-10.4%) |
| Mar 2018 | - | $26.13M(-28.5%) |
| Dec 2017 | $36.47M(+31.1%) | $36.53M(+28.5%) |
| Sep 2017 | - | $28.42M(+12.8%) |
| Jun 2017 | - | $25.19M(+8.4%) |
| Mar 2017 | - | $23.25M(-402.4%) |
| Dec 2016 | $27.82M(+41.5%) | -$7.69M(-77.4%) |
| Sep 2016 | - | -$33.97M(-319.0%) |
| Jun 2016 | - | $15.51M(+29.8%) |
| Mar 2016 | - | $11.95M(-35.8%) |
| Dec 2015 | $19.67M(+13.9%) | $18.63M(+11.6%) |
| Sep 2015 | - | $16.69M(-1.7%) |
| Jun 2015 | - | $16.98M(+28.9%) |
| Mar 2015 | - | $13.18M(-0.2%) |
| Dec 2014 | $17.27M(+14.4%) | $13.20M(-13.7%) |
| Sep 2014 | - | $15.29M(-4.9%) |
| Jun 2014 | - | $16.07M(-3.4%) |
| Mar 2014 | - | $16.64M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $15.09M(+21.4%) | $17.83M(+5.0%) |
| Sep 2013 | - | $16.98M(+6.4%) |
| Jun 2013 | - | $15.96M(+19.6%) |
| Mar 2013 | - | $13.34M(+16.1%) |
| Dec 2012 | $12.43M(-8.5%) | $11.49M(-1.4%) |
| Sep 2012 | - | $11.65M(+353.6%) |
| Jun 2012 | - | $2.57M(-16.0%) |
| Mar 2012 | - | $3.06M(-71.5%) |
| Dec 2011 | $13.59M(-4.3%) | $10.71M(+0.3%) |
| Sep 2011 | - | $10.67M(-21.8%) |
| Jun 2011 | - | $13.65M(+16.1%) |
| Mar 2011 | - | $11.75M(-4.2%) |
| Dec 2010 | $14.20M(-74.4%) | $12.27M(-1.8%) |
| Sep 2010 | - | $12.49M(+269.5%) |
| Jun 2010 | - | $3.38M(-72.8%) |
| Mar 2010 | - | $12.41M(+0.1%) |
| Dec 2009 | $55.47M(-19.6%) | $12.40M(+50.7%) |
| Sep 2009 | - | $8.23M(-114.3%) |
| Jun 2009 | - | -$57.60M(-628.4%) |
| Mar 2009 | - | $10.90M(-2.3%) |
| Dec 2008 | $69.03M(-1.5%) | $11.16M(-21.5%) |
| Sep 2008 | - | $14.22M(-11.3%) |
| Jun 2008 | - | $16.04M(+5.6%) |
| Mar 2008 | - | $15.19M(+1.5%) |
| Dec 2007 | $70.11M(+8.8%) | $14.96M(+13.3%) |
| Sep 2007 | - | $13.20M(-9.4%) |
| Jun 2007 | - | $14.56M(+5.8%) |
| Mar 2007 | - | $13.76M(-18.9%) |
| Dec 2006 | $64.47M(+20.4%) | $16.98M(+6.1%) |
| Sep 2006 | - | $16.00M(+7.5%) |
| Jun 2006 | - | $14.89M(+10.6%) |
| Mar 2006 | - | $13.47M(+15.2%) |
| Dec 2005 | $53.55M(+3.2%) | $11.70M(+9.0%) |
| Sep 2005 | - | $10.73M(-3.4%) |
| Jun 2005 | - | $11.10M(-0.1%) |
| Mar 2005 | - | $11.11M(-18.9%) |
| Dec 2004 | $51.88M(+20.2%) | $13.70M(+11.6%) |
| Sep 2004 | - | $12.28M(+359.5%) |
| Jun 2004 | - | $2.67M(+8.0%) |
| Mar 2004 | - | $2.48M(-66.0%) |
| Dec 2003 | $43.17M(+22.0%) | - |
| Jun 2003 | - | $7.29M(-6.1%) |
| Mar 2003 | - | $7.76M |
| Dec 2002 | $35.38M(+31.7%) | - |
| Dec 2001 | $26.86M(+94.7%) | - |
| Dec 2000 | $13.79M | - |
FAQ
- What is Cytokinetics, Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual operating expenses year-on-year change?
- What is Cytokinetics, Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly operating expenses year-on-year change?
What is Cytokinetics, Incorporated annual total operating expenses?
The current annual operating expenses of CYTK is $215.31M
What is the all time high annual operating expenses for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual total operating expenses is $215.31M
What is Cytokinetics, Incorporated annual operating expenses year-on-year change?
Over the past year, CYTK annual total operating expenses has changed by +$41.70M (+24.02%)
What is Cytokinetics, Incorporated quarterly total operating expenses?
The current quarterly operating expenses of CYTK is $175.99M
What is the all time high quarterly operating expenses for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly total operating expenses is $175.99M
What is Cytokinetics, Incorporated quarterly operating expenses year-on-year change?
Over the past year, CYTK quarterly total operating expenses has changed by +$47.98M (+37.48%)